| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gabor Kandel | |
| Joshua Butt | |||
| P2860 | cites work | Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis | Q24602426 |
| Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study | Q24609281 | ||
| Epidemiology of esophageal cancer | Q24625927 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Radiofrequency ablation in Barrett's esophagus with dysplasia | Q28246453 | ||
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
| The molecular biology of esophageal adenocarcinoma. | Q30351850 | ||
| Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas | Q30544316 | ||
| Age- and sex-specific yield of Barrett's esophagus by endoscopy indication | Q33618456 | ||
| Is there publication bias in the reporting of cancer risk in Barrett's esophagus? | Q33993884 | ||
| Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy | Q34028377 | ||
| Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study | Q34099177 | ||
| American Gastroenterological Association medical position statement on the management of Barrett's esophagus | Q34168686 | ||
| Principles and practice of mass screening for disease | Q34204659 | ||
| Incidence of adenocarcinoma among patients with Barrett's esophagus | Q34223900 | ||
| Oesophageal carcinoma | Q34325751 | ||
| Prevalence of Barrett's esophagus in Korea | Q34412088 | ||
| Prevalence of Barrett's esophagus in the general population: an endoscopic study | Q34475247 | ||
| Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus | Q34633567 | ||
| Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma | Q34703662 | ||
| Meta‐analysis: the association of oesophageal adenocarcinoma with symptoms of gastro‐oesophageal reflux | Q36348405 | ||
| Helicobacter pylori and esophageal cancer risk: a meta-analysis | Q36410246 | ||
| Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study | Q36783294 | ||
| Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis | Q37018235 | ||
| A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease | Q37506042 | ||
| Prediction of Barrett's esophagus among men. | Q37519245 | ||
| Age at onset of GERD symptoms predicts risk of Barrett's esophagus | Q37678177 | ||
| Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated | Q37749477 | ||
| Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population | Q37856582 | ||
| Barrett's oesophagus in Asians--are ethnic differences due to genes or the environment? | Q37875903 | ||
| The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis | Q37945514 | ||
| Screening for oesophageal cancer. | Q37995081 | ||
| A global assessment of the oesophageal adenocarcinoma epidemic | Q38430776 | ||
| Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison | Q38450063 | ||
| The prevalence of and risk factors for Barrett's esophagus in a Korean population: A nationwide multicenter prospective study. | Q38495124 | ||
| Continuing rapid increase in esophageal adenocarcinoma in England and Wales | Q39171596 | ||
| Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. | Q41215729 | ||
| Changing patterns in the incidence of esophageal and gastric carcinoma in the United States | Q43873434 | ||
| Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
| Hot beverage and food intake and esophageal cancer in southern China. | Q44052250 | ||
| Population attributable risks of esophageal and gastric cancers | Q44586583 | ||
| Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus. | Q45241541 | ||
| Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study | Q46115635 | ||
| Surveillance and survival in Barrett's adenocarcinomas: a population-based study | Q46131128 | ||
| Trends in oesophageal cancer incidence and mortality in Europe | Q46909078 | ||
| Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. | Q50713853 | ||
| Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005. | Q51136825 | ||
| Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. | Q51148501 | ||
| Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study. | Q51211828 | ||
| Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea. | Q51807989 | ||
| [The prevalence of Barrett's esophagus and the comparison of Barrett's esophagus with cardiac intestinal metaplasia in the health screening at a secondary care hospital]. | Q53356372 | ||
| Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. | Q53679889 | ||
| Esophageal Cancer | Q56209683 | ||
| [The prevalence of esophageal disorders in the subjects examined for health screening] | Q57211968 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus | Q59705210 | ||
| Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus | Q60168150 | ||
| Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan | Q74215415 | ||
| Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer | Q77738544 | ||
| Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all | Q79975061 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Esophageal cancer: epidemiology, pathogenesis and prevention | Q81740906 | ||
| Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians | Q85602178 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 40-46 | |
| P577 | publication date | 2014-01-24 | |
| P1433 | published in | Clinical endoscopy | Q26842801 |
| P1476 | title | Barrett esophagus: when to endoscope | |
| P478 | volume | 47 |
| Q36979244 | Diagnostic Accuracy of Mucosal Biopsy versus Endoscopic Mucosal Resection in Barrett's Esophagus and Related Superficial Lesions |
| Q35086878 | Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directions |
| Q35340638 | Surveillance in Barrett esophagus |
Search more.